1.
Cavalletto L, Bernardinello E, Diodati G, et al. Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice. Farmeconomia. Health Economics and Therapeutic Pathways. 2008;9(4):173-181. https://doi.org/10.7175/fe.v9i4.235